CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties

Stem Cell Research

Volumn 10, Issue 3, 2013, Pages 477-488

  Martens de Kemp, Sanne R ^a   Brink, Arjen ^a   Stigter van Walsum, Marijke ^a   Damen, J Mirjam A ^b   Rustenburg, François ^a   Wu, Thijs ^a   Van Wieringen, Wessel N ^a,c   Schuurhuis, Gerrit Jan ^a   Braakhuis, Boudewijn J M ^a   Slijper, Monique ^b   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD98 ANTIGEN; MONOCLONAL ANTIBODY; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CELL CYCLE REGULATION; CELL DIFFERENTIATION; DNA REPAIR; FLOW CYTOMETRY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD44; ANTIGENS, CD98; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CLUSTER ANALYSIS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTOME; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 84875641215     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.02.004     Document Type: Article

References (37)

1. Akervall J., Guo X., Qian C.N., Schoumans J., Leeser B., Kort E., Cole A., Resau J., Bradford C., Carey T., Wennerberg J., Anderson H., Tennvall J., Teh B.T. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Clin. Cancer Res. 2004, 10:8204-8213.
2. Al Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3983-3988.
3. Armulik A., Velling T., Johansson S. The integrin beta1 subunit transmembrane domain regulates phosphatidylinositol 3-kinase-dependent tyrosine phosphorylation of Crk-associated substrate. Mol. Biol. Cell 2004, 15:2558-2567.
4. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990, 61:1303-1313.
5. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
6. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
7. Esseghir S., Reis-Filho J.S., Kennedy A., James M., O'Hare M.J., Jeffery R., Poulsom R., Isacke C.M. Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts. J. Pathol. 2006, 210:420-430.
8. Feral C.C., Nishiya N., Fenczik C.A., Stuhlmann H., Slepak M., Ginsberg M.H. CD98hc (SLC3A2) mediates integrin signaling. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:355-360.
9. Gibbs S., Fijneman R., Wiegant J., van Kessel A.G., van De P.P., Backendorf C. Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics 1993, 16:630-637.
10. Henderson N.C., Collis E.A., Mackinnon A.C., Simpson K.J., Haslett C., Zent R., Ginsberg M., Sethi T. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J. Biol. Chem. 2004, 279:54731-54741.
11. Ichinoe M., Mikami T., Yoshida T., Igawa I., Tsuruta T., Nakada N., Anzai N., Suzuki Y., Endou H., Okayasu I. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Pathol. Int. 2011, 61:281-289.
12. Imai H., Kaira K., Oriuchi N., Yanagitani N., Sunaga N., Ishizuka T., Kanai Y., Endou H., Nakajima T., Mori M. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology 2009, 54:804-813.
13. Joshua B., Kaplan M.J., Doweck I., Pai R., Weissman I.L., Prince M.E., Ailles L.E. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck 2012, 34:42-49.
14. Kaira K., Oriuchi N., Imai H., Shimizu K., Yanagitani N., Sunaga N., Hisada T., Tanaka S., Ishizuka T., Kanai Y., Endou H., Nakajima T., Mori M. Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. Br. J. Cancer 2008, 98:742-748.
15. Kaira K., Oriuchi N., Imai H., Shimizu K., Yanagitani N., Sunaga N., Hisada T., Ishizuka T., Kanai Y., Endou H., Nakajima T., Mori M. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. Cancer Sci. 2009, 100:248-254.
16. Kaira K., Oriuchi N., Imai H., Shimizu K., Yanagitani N., Sunaga N., Hisada T., Kawashima O., Kamide Y., Ishizuka T., Kanai Y., Nakajima T., Mori M. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases. Ann. Surg. Oncol. 2009, 16:3473-3481.
17. Kaira K., Takahashi T., Abe M., Akamatsu H., Nakagawa K., Ohde Y., Okumura T., Murakami H., Tsuya A., Nakamura Y., Naito T., Kondo H., Nakajima T., Endo M., Yamamoto N. CD98 expression is associated with the grade of malignancy in thymic epithelial tumors. Oncol. Rep. 2010, 24:861-867.
18. Koukourakis M.I., Giatromanolaki A., Tsakmaki V., Danielidis V., Sivridis E. Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer. Br. J. Cancer 2012, 106:846-853.
19. Leemans C.R., Braakhuis B.J., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 2011, 11:9-22.
20. Lin C.J., Grandis J.R., Carey T.E., Gollin S.M., Whiteside T.L., Koch W.M., Ferris R.L., Lai S.Y. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck 2007, 29:163-188.
21. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75:4646-4658.
22. Perez, A., Neskey, D.M., Wen, J., Pereira, L., Reategui, E.P., Goodwin, W.J., Carraway, K.L., Franzmann, E.J., in press. CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression. Oral Oncol.
23. Pignon J.P., Bourhis J., Domenge C., Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000, 355:949-955.
24. Pramana J., van Den Brekel M.W., van Velthuysen M.L., Wessels L.F., Nuyten D.S., Hofland I., Atsma D., Pimentel N., Hoebers F.J., Rasch C.R., Begg A.C. Gene expression profiling to predict outcome after chemoradiation in head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69:1544-1552.
25. Pries R., Witrkopf N., Trenkle T., Nitsch S.M., Wollenberg B. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo 2008, 22:89-92.
26. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:973-978.
27. Quak J.J., Schrijvers H.G., Brakkee J.G., Davis H.D., Scheper R.J., Meijer C.J., Snow G.B., van Dongen G.A. Expression and characterization of two differentiation antigens in human stratified squamous epithelia and carcinomas. Int. J. Cancer 1992, 50:507-513.
28. Rosland G.V., Svendsen A., Torsvik A., Sobala E., McCormack E., Immervoll H., Mysliwietz J., Tonn J.C., Goldbrunner R., Lonning P.E., Bjerkvig R., Schichor C. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009, 69:5331-5339.
29. Sakata T., Ferdous G., Tsuruta T., Satoh T., Baba S., Muto T., Ueno A., Kanai Y., Endou H., Okayasu I. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Pathol. Int. 2009, 59:7-18.
30. Shevchenko A., Tomas H., Havlis J., Olsen J.V., Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 2006, 1:2856-2860.
31. Shiras A., Chettiar S.T., Shepal V., Rajendran G., Prasad G.R., Shastry P. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells 2007, 25:1478-1489.
32. Shishido T., Uno S., Kamohara M., Tsuneoka-Suzuki T., Hashimoto Y., Enomoto T., Masuko T. Transformation of BALB3T3 cells caused by over-expression of rat CD98 heavy chain (HC) requires its association with light chain: mis-sense mutation in a cysteine residue of CD98HC eliminates its transforming activity. Int. J. Cancer 2000, 87:311-316.
33. Teng I.W., Hou P.C., Lee K.D., Chu P.Y., Yeh K.T., Jin V.X., Tseng M.J., Tsai S.J., Chang Y.S., Wu C.S., Sun H.S., Tsai K.D., Jeng L.B., Nephew K.P., Huang T.H., Hsiao S.H., Leu Y.W. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res. 2011, 71:4653-4663.
34. Van Hal N.L., van Dongen G.A., Stigter-van W.M., Snow G.B., Brakenhoff R.H. Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma. Int. J. Cancer 1999, 82:837-845.
35. Verrey F. System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch. 2003, 445:529-533.
36. Welters M.J., Fichtinger-Schepman A.M., Baan R.A., Hermsen M.A., van der Vijgh W.J., Cloos J., Braakhuis B.J. Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines. Int. J. Cancer 1997, 71:410-415.
37. Wilson, G.D., Marples, B., Galoforo, S., Geddes, T.J., Thibodeau, B.J.,Grenman, R., Akervall, J., in press. Isolation and genomic characterization of stem cells in head and neck cancer. Head Neck.